High intensity focused ultrasound in clinical tumor ablation

doi:10.5306/wjco.v2.i1.8

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (18510)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

1104

HTML

16784

Figures (1-9)

332

Tables (1-2)

290

Sum=18510

Jan 10, 2011 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (444)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Jan 10, 2011; 2(1): 8-27
Published online Jan 10, 2011. doi: 10.5306/wjco.v2.i1.8

Full Size Figure Download Figure

Figure 3 Complete destruction of the glandular tissue due to coagulation necrosis lesion which reaches the capsula and the periprostatic fat 48 h after high intensity focused ultrasound treatment (A) and the necrotic prostatic tissue is replaced by a fibrotic tissue, including the capsula, 3 mo after high intensity focused ultrasound therapy (B).

Citation: Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol 2011; 2(1): 8-27
URL: https://www.wjgnet.com/2218-4333/full/v2/i1/8.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i1.8